Matches in Wikidata for { <http://www.wikidata.org/entity/Q91715524> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91715524 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91715524 description "scientific article published on 07 April 2020" @default.
- Q91715524 description "wetenschappelijk artikel" @default.
- Q91715524 description "наукова стаття, опублікована 7 квітня 2020" @default.
- Q91715524 name "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 name "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 type Item @default.
- Q91715524 label "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 label "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 prefLabel "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 prefLabel "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 P1433 Q91715524-15FFD923-18DA-4E09-AB53-D4489440AE73 @default.
- Q91715524 P1476 Q91715524-C9FFE6AF-5A78-4C30-BC4A-D9B82B6D8171 @default.
- Q91715524 P2093 Q91715524-34C421DD-2256-43EC-A15D-F4397BF35012 @default.
- Q91715524 P2093 Q91715524-3CEE1FF7-88C5-40EC-AEC9-8071D1EC7BBF @default.
- Q91715524 P2093 Q91715524-5EDD6A87-C834-4247-B217-1F182D70FF33 @default.
- Q91715524 P2093 Q91715524-82488303-63BE-4FD6-BDB0-5FB2B968332B @default.
- Q91715524 P2093 Q91715524-CDA2582F-C509-44DE-9627-1D498C2F89D7 @default.
- Q91715524 P2093 Q91715524-D0FA9D30-BBDF-48C8-8D8A-C5CDA13B0A65 @default.
- Q91715524 P2093 Q91715524-F3CD9B11-F353-4BD2-9192-2312153ED4CC @default.
- Q91715524 P2093 Q91715524-FE84D59D-692A-4B38-BE24-8624E14DB193 @default.
- Q91715524 P31 Q91715524-E14F237C-32DF-4F56-83DE-8F9703F9E97F @default.
- Q91715524 P356 Q91715524-626F2B66-F3DD-4427-B375-2F52AB644C45 @default.
- Q91715524 P577 Q91715524-9D5226D3-812E-411D-9994-68A497ABAE09 @default.
- Q91715524 P698 Q91715524-8B5EA8DC-4BFC-44C7-9F04-FD97EA47E84D @default.
- Q91715524 P932 Q91715524-37427261-7268-40C1-BB27-F96B9E6435FB @default.
- Q91715524 P356 S00280-020-04062-8 @default.
- Q91715524 P698 32266457 @default.
- Q91715524 P1433 Q326137 @default.
- Q91715524 P1476 "A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors" @default.
- Q91715524 P2093 "Lian Guo" @default.
- Q91715524 P2093 "Lianke Liu" @default.
- Q91715524 P2093 "Lingxiang Liu" @default.
- Q91715524 P2093 "Tongshan Wang" @default.
- Q91715524 P2093 "Yiqian Liu" @default.
- Q91715524 P2093 "Yixiang Wang" @default.
- Q91715524 P2093 "Yongqian Shu" @default.
- Q91715524 P2093 "Zhengzhen Gao" @default.
- Q91715524 P31 Q13442814 @default.
- Q91715524 P356 "10.1007/S00280-020-04062-8" @default.
- Q91715524 P577 "2020-04-07T00:00:00Z" @default.
- Q91715524 P698 "32266457" @default.
- Q91715524 P932 "7188728" @default.